Skip to content
Screener

BioMarin Pharmaceuticals BMRN EBITDA

EBITDA at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$23.7M-81.3%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$60.37M-93.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$17.14M+125%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$109.2M+13.2%
Regenxbio logo
RegenxbioRGNX
$33.02M+156%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——

Other financials

Income statement

See full
Revenue$989.7M+19.9%
Gross profit$786.9M+16.5%
Operating income$110.9M-59.9%
Net income$44.8M-81.4%
EPS (diluted)$0.23-81.3%

Balance sheet

See full
Cash & equivalents$874.0M-28.0%
Total debt$4.2B+598%
Total equity$6.3B+4.9%
Total assets$11.7B+57.2%

Cash flow

See full
Operating cash flow$168.1M-9.3%
CapEx$28.8M+68.5%
Free cash flow$139.3M-17.2%

Valuation

See full
Market cap$11.58B-0.6%
Enterprise value$14.89B+34.9%
P/E32.2×-34.7×
P/S3.4×-0.4×

Profitability

See full
Gross margin76.1%-3.4pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin21.7%-1.0pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.7×+0.6×
Current ratio2.4×-3.2×

Where this comes from

Calculated from BioMarin Pharmaceuticals’s reported figures.

$110.9Mebit+
$97.6MDepreciation Depletion & Amortization
=$208.56M

The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001048477-26-000016

FAQ

What is BioMarin Pharmaceuticals's EBITDA?
BioMarin Pharmaceuticals (BMRN) reported EBITDA of $208.56M in Q2 2026.
How has BioMarin Pharmaceuticals's EBITDA changed year-over-year?
BioMarin Pharmaceuticals's EBITDA decreased by 29.4% year-over-year, from $295.45M to $208.56M.
What is the long-term trend for BioMarin Pharmaceuticals's EBITDA?
Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's EBITDA has grown at a 113.7% compound annual growth rate (CAGR), from $25.7M to $536.42M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about BioMarin Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude